Announced Fri, 3 Jul · 13:06 IST
Bliss GVS files quarterly demat compliance certificate
Compliance View source PDF
BLISSGVS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-6.8%1-day move
₹525.70
prior close
—
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
————-6.8-3.6-3.3+0.2-0.1-0.9-12.1———
Up moveDown movePending
AI summary
Bliss GVS Pharma has filed a routine compliance certificate from its registrar MUFG Intime India for the quarter ended June 30, 2026. Under SEBI's Depositories Regulations, the registrar confirms that share certificates received for dematerialisation were processed within prescribed timelines and depositories were recorded as the registered owners. This is a standard quarterly procedural filing with no corporate action involved.
Likely market impact
Routine regulatory filing. No impact on operations, financials, or shareholders. No expected stock price reaction.